Top

Published in:

01-12-2005 | Original Article

Claudin expression in Barrett's esophagus and adenocarcinoma

Authors: Hajnalka Gyõrffy, Ágnes Holczbauer, Pál Nagy, Zsuzsa Szabó, Péter Kupcsulik, Csilla Páska, János Papp, Zsuzsa Schaff, András Kiss

Published in: Virchows Archiv | Issue 6/2005

Abstract

Claudins (CLDNs) are key molecules in cell adhesion, polarity, and control of paracellular solute transport. Several studies suggested that changes in claudin pattern have a role in cancer development. This study aimed to detect alterations in CLDN 1, 2, 3, 4, and 7 expression patterns in Barrett's esophagus (BE) and adenocarcinoma (ACC) compared with that in foveolar epithelium (FOV), normal squamous epithelium (SQ), and squamous cell carcinoma (SQCC). One hundred twenty five surgically or endoscopically removed, paraffin-embedded cases were studied by immunohistochemistry and analyzed statistically. BE, ACC, and FOV were dissected from 30 paraffin-embedded samples for further mRNA expression analysis. CLDN 7 was the dominating type in all epithelia and carcinomas, but its expression did not differ in normal and altered tissues. CLDN 1 expression was significantly increased in SQCC compared with that in SQ. CLDNs 3 and 4 were significantly elevated both in BE and ACC compared with that in FOV. CLDN 2 expression increased significantly in ACCs compared with that in BE. This is the first report proving similarities and differences regarding claudin expression pattern in BE and ACC compared with that in FOV and SQ. Our data prove a close link in CLDN pattern between BE and ACC, adding further evidence that BE is an alteration preceding esophageal ACC.

Amasheh S, Meiri N, Gitter AH, Schoneberg T, Mankertz J, Schulzke JD, Fromm M (2002) Claudin-2 expression induces cation-selective channels in tight junctions of epithelial cells. J Cell Sci 115:4969–4976CrossRefPubMed

Bailey T, Biddlestone L, Shepher N, Barr H, Warner P, Jankowski J (1998) Altered cadherin and catenin complexes in the Barrett's esophagus–dysplasia–adenocarcinoma sequence. Correlation with disease progression and dedifferentiation. Am J Pathol 152:135–144PubMed

Blot WJ, Devesa SS, Kneller RW, Fraumeni JF Jr (1991) Rising incidence of adeno-carcinoma of the esophagus and gastric cardia. JAMA 265:1287–1289CrossRefPubMed

Bottger TC, Youssef V, Dutkowski P, Maschek H, Brenner W, Junginger T (1998) Expression of CD44 variant proteins in adenocarcinoma of Barrett's esophagus and its relation to prognosis. Cancer 83:1074–1080CrossRefPubMed

Cameron AJ (2002) Epidemiology of Barrett's esophagus and adenocarcinoma. Dis Esophagus 15:106–108CrossRefPubMed

Escaffit F, Boudreau F, Beaulieu JF (2005) Differential expression of claudin-2 along the human intestine: implication of GATA-4 in the maintenance of claudin-2 in differentiating cells. J Cell Physiol 203:15–26CrossRefPubMed

Furuse M, Sasaki H, Tsukita S (1999) Manner of interaction of heterogeneous claudin species within and between tight junction strands. J Cell Biol 147:891–903CrossRefPubMed

Furuse M, Furuse K, Sasaki H, Tsukita S (2001) Conversion of zonulae occludentes from tight to leaky strand type by introducing claudin-2 into Madin-Darby canine kidney I cells. J Cell Biol 153:263–272CrossRefPubMed

Hamelin R, Flejou JF, Muzeau F, Potet F, Laurent-Puig P, Fekete F, Thomas G (1994) TP53 gene mutations and p53 protein immunoreactivity in malignant and premalignant Barrett's esophagus. Gastroenterology 107:1012–1018PubMed

10.

Hamilton SR, Smith RR (1987) The relationship between columnar epithelial dysplasia and invasive adenocarcinoma arising in Barrett's esophagus. Am J Clin Pathol 87:301–312PubMed

11.

Heinzelmann-Schwarz VA, Gardiner-Garden M, Henshall SM, Scurry J, Scolyer RA, Davies MJ (2004) Overexpression of the cell adhesion molecules DDR1, Claudin 3, and Ep-CAM in metaplastic ovarian epithelium and ovarian cancer. Clin Cancer Res 10:4427–4436PubMedCrossRef

12.

Hirohashi S, Kanal Y (2003) Cell adhesion system and human cancer morphogenesis. Cancer Sci 94:575–581CrossRefPubMed

13.

Hourihan RN, O'Sullivan GC, Morgan JG (2003) Transcriptional gene expression profiles of oesophageal adenocarcinoma and normal oesophageal tissues. Anticancer Res 23:161–165PubMed

14.

Katahira J, Inoue N, Horiguchi Y, Matsuda M, Sugimoto N (1997) Molecular cloning and functional characterization of the receptor for Clostridium perfringens enterotoxin. J Cell Biol 136:1239–1247CrossRefPubMed

15.

Kimura Y, Shiozaki H, Hirao M, Maeno Y, Doki Y, Inoue M, Monden T Ando-Akatsuka Y, Furuse M, Tsukita S, Monden M (1997) Expression of occludin, tight-junction-associated protein, in human digestive tract. Am J Pathol 151:45–54PubMed

16.

Kominsky SL, Argani P, Korz D, Evron E, Raman V, Garrett E, Rein A, Sauter G, Kallioniemi O-P, Sukumar S (2003) Loss of the tight junction protein claudin-7 correlates with histological grade in both ductal carcinoma in situ and invasive ductal carcinoma of the breast. Oncogene 22:2021–2033CrossRefPubMed

17.

Krishnadath KK, Tilanus HW, van Blankenstein M, Hop WCJ, Kremers ED, Dinjens WNM, Bosman FT (1997) Reduced expression of the cadherin–catenin complex in oesophageal adenocarcinoma correlates with poor prognosis. J Pathol 182:331–338CrossRefPubMed

18.

Lagorce-Pagès C, Paraf F, Wendum D, Martin A, Fléjou J-F (2004) Expression of inflammatory secretory phospholipase A2 and cytosolic phospholipase A2 in premalignant and malignant Barrett's oesophagus. Virchows Arch 444:426–435CrossRefPubMed

19.

Langbein L, Grund C, Kuhn C, Praetzel S, Kartenbeck J, Brandner JM, Moll I, Franke WW (2002) Tight junctions and compositionally related junctional structures in mammalian stratified epithelia and cell cultures derived therefrom. Eur J Cell Biol 81:419–435CrossRefPubMed

20.

Lódi C, Kiss A, Holczbauer Á, Batmunkh E, Paku S, Illyés G, Kupcsulik P, Schaff Z (2004) High expression of claudin 4 in human cholangiocellular carcinomas. Gastroenterology Week Freiburg 2004: Gastroenterology yesterday–today–tomorrow: a review and preview. FALK symposium no. 144, Freiburg, Germany, October 16–17

21.

Long H, Crean CD, Lee WH, Cummings OW, Gabig TG (2001) Expression of Clostridium perfringens enterotoxin receptors claudin-3 and claudin-4 in prostate cancer epithelium. Cancer Res 61:7878–7881PubMed

22.

Matsuda M, Kubo A, Furuse M, Tsukita S (2004) A peculiar internalization of claudins, tight junction-specific adhesion molecules, during the intercellular movement of epithelial cells. J Cell Sci 117:1247–1257CrossRefPubMed

23.

Michl P, Buchholz M, Rolke M, Kunsch S, Lohr M, McClane B, Tsukita S, Leder G, Adler G, Gress TM (2001) Claudin-4: a new target for pancreatic cancer treatment using Clostridium perfringens enterotoxin. Gastroenterology 121:678–684CrossRefPubMed

24.

Miwa N, Furuse M, Tsukita S, Niikawa N, Nakamura Y, Furukawa Y (2001) Involvement of claudin-1 in the β-catenin/Tcf signaling pathway and its frequent upregulation in human colorectal cancers. Oncol Res 12:469–476PubMed

25.

Mueller J, Werner M, Stolte M (2004) Barrett's esophagus: histopathologic definitions and diagnostic criteria. World J Surg 28:148–154CrossRefPubMed

26.

Nichols LS, Ashfaq R, Iacobuzio-Donahue CA (2004) Claudin 4 protein expression in primary and metastatic pancreatic cancer: support for use as a therapeutic target. Am J Clin Pathol 121:226–230CrossRefPubMed

27.

Offner S, Hekele A, Teichmann U, Weinberger S, Gross S, Kufer P, Itin C, Baeuerle PA, Kohleisen B (2004) Epithelial tight junction proteins as potential antibody targets for pancarcinoma therapy. Cancer Immunol Immunother 54:431–445CrossRefPubMed

28.

Páska C, Bögi K, Szilák L, Tõkés AM, Szabó E, Sziller I, Rigó J, Sobel G, Szabó I, Kaposi-Novák P, Kiss A, Schaff Z (2004) Effect of formalin, acetone and RNAlater fixatives on tissue preservation and different size amplicons by real-time PCR from paraffin-embedded tissue. Diagn Mol Pathol 13:234–240CrossRefPubMed

29.

Pfaffl MW, Horgan GW, Dempfle L (2002) Relative expression software tool (REST) for group-wise comparison and statistical analysis of relative expression results in real-time PCR. Nucleic Acids Res 30:e36CrossRefPubMed

30.

Rahner C, Mitic LL, Anderson JM (2002) Heterogeneity in expression and subcellular localization of claudins 2, 3, 4 and 5 in the rat liver, pancreas, and gut. Gastroenterology 120:411–422CrossRef

31.

Resnick MB, Konkin T, Routhier J, Sabo E, Pricolo VE (2005) Claudin-1 is a strong prognostic indicator in stage II colonic cancer: a tissue microarray study. Mod Pathol 18:511–518CrossRefPubMed

32.

Sarbia M, Donner A, Franke C, Gabbert HE (2004) Distinction between intestinal metaplasia in the cardia and in Barrett's esophagus: the role of histology and immunohistochemistry. Human Pathol 35:371–376CrossRef

33.

Sawada N, Murata M, Kikuchi K, Osanai M, Tobioka H, Kojima T, Chiba H (2003) Tight junctions and human diseases. Med Electron Microsc 36:147–156CrossRefPubMed

34.

Singh AB, Harris RC (2004) Epidermal growth factor receptor activation differentially regulates claudin expression and enhances transepithelial resistance in Madin-Darby canine kidney cells. J Biol Chem 279:3543–3552CrossRefPubMed

35.

Sobel G, Páska C, Szabó I, Kiss A, Kádár A, Schaff Z (2005) Increased expression of claudins in cervical squamous intraepithelial neoplasia and invasive carcinoma. Human Pathol 36:162–169CrossRef

36.

Swami S, Kumble S, Triadafilopoulos G (1995) E-cadherin expression in gastro-esophageal reflux disease, Barrett's esophagus, and esophageal adenocarcinoma: an immunohistochemical and immunoblot study. Am J Gastroenterol 90:1808–1813 37PubMed

37.

Tanaka Y, Mimori K, Shiraishi T, Okhura Y, Takubo K, Mafune K, Barnard GF, Mori M (2000) Alpha 6 integrin expression in esophageal carcinoma. Int J Oncol 16:725–729PubMed

38.

Tõkés AM, Kulka J, Paku S, Szik Á, Páska Cs, Kaposi Novák P, Szilák L, Kiss A, Bögi K, Schaff Zs (2005) Claudin 1, 3 and 4 and proteins and mRNA expression in benign and malignant breast lesions: a research study. Breast Cancer Res 7:R296–R305CrossRefPubMed

39.

van Dekken H, Geelen E, Dinjens WN Wijnhoven BP, Tilanus HW, Tanke HJ, Rosenberg C (1999) Comparative genomic hybridization of cancer of the gastro-esophageal (Barrett's) and gastric cardia adenocarcinomas. Cancer Res 59:748–752PubMed

40.

Vieth M, Schneider-Stock R, Röhrich K, May A, Ell C, Markwarth A, Roessner A, Stolte M, Tannapfel A (2004) INK4a-ARF alterations in Barrett's epithelium, intraepithelial neoplasia and Barrett's adenocarcinoma. Virchows Arch 445:135–141CrossRefPubMed

41.

Walch A, Specht K, Bink K, Zitzelbarger H, Braselmann H, Bauer M, Aubele M, Stein H, Siewert JR, Hofler H, Werner M (2001) Her-2/neu gene amplification, elevated mRNA expression and protein overexpression in the metaplasia–dysplasia–adenocarcinoma sequence of Barrett's esophagus. Lab Invest 81:791–801PubMed

42.

Weng XH, Beyenbach KW, Quaroni A (2005) Cultured monolayers of the dog jejunum with the structural and functional properties resembling the normal epithelium. Am J Physiol Gastrointest Liver Physiol 288:G705–G717CrossRefPubMed

Title: Claudin expression in Barrett's esophagus and adenocarcinoma
Authors: Hajnalka Gyõrffy
Ágnes Holczbauer
Pál Nagy
Zsuzsa Szabó
Péter Kupcsulik
Csilla Páska
János Papp
Zsuzsa Schaff
András Kiss
Publication date: 01-12-2005
Publisher: Springer-Verlag
Published in: Virchows Archiv / Issue 6/2005
Print ISSN: 0945-6317
Electronic ISSN: 1432-2307
DOI: https://doi.org/10.1007/s00428-005-0045-9

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Claudin expression in Barrett's esophagus and adenocarcinoma

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 6/2005

Mucinous tubular and spindle cell carcinoma: a report of 15 cases and a review of the literature

Problems in Breast Pathology

Can renal oncocytoma be differentiated from its renal mimics? The utility of anti-mitochondrial, caveolin 1, CD63 and cytokeratin 14 antibodies in the differential diagnosis

Multiple calcifying fibrous tumor of the pleura

Unusual sarcomatoid neoplasm of the lung suggesting a myofibrosarcoma

Immunohistochemistry in bone marrow pathology: a useful adjunct for morphologic diagnosis